Concepedia

Susanne Jung-Munkwitz

SJ

Statistics

Publications

3

Citations

640

H-Index

3

Active since

2009

Affiliations

Ludwig-Maximilians-Universität München(Current)

Zimmer Biomet (Germany)

University Hospital Ulm

Medizinische Fakultät Mannheim

Evangelisches Krankenhaus Hamm

Susanne Jung-Munkwitz is an author at Ludwig-Maximilians-Universität München specializing in immunotherapy, pharmacotherapy, and hematology.

Publications per year

2009–2011

3

Publications

3

Tolerability-Adapted Imatinib 800 mg/d Versus 400 mg/d Versus 400 mg/d Plus Interferon-α in Newly Diagnosed Chronic Myeloid Leukemia

Rüdiger Hehlmann, Michael Lauseker, Susanne Jung-Munkwitz et al. · Journal of Clinical Oncology · 2011 · 323 citations · Full text

, , +12

Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV

Alice Fabarius, Armin Leitner, Andreas Hochhaus et al. · Blood · 2011 · 290 citations

, , +16

Randomized Comparison of Imatinib 800 Mg Vs. Imatinib 400 Mg +/- IFN in Newly Diagnosed BCR/ABL Positive Chronic Phase CML: Analysis of Molecular Remission at 12 Months; The German CML-Study IV.

Rüdiger Hehlmann, Susanne Jung-Munkwitz, Michael Lauseker et al. · Blood · 2009 · 27 citations

, , +8

1–3 of 3